• Users Online: 526
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Reader Login
Export selected to
Endnote
Reference Manager
Procite
Medlars Format
RefWorks Format
BibTex Format
  Most cited articles *

 
 
  Archives   Most popular articles   Most cited articles
 
Show all abstracts  Show selected abstracts  Export selected to
  Cited Viewed PDF
EDITORIAL
Steroid containing fixed drug combinations banned by government of India: A big step towards dermatologic drug safety
Sushil Pande
January-June 2016, 2(1):1-2
DOI:10.4103/2455-3972.184102  
  4 6,071 300
REVIEW ARTICLES
Itraconazole: What clinicians should know?
Piet De Doncker, Sushil Pande, Ute Richarz, Nishant Garodia
January-June 2017, 3(1):4-10
DOI:10.4103/ijdd.ijdd_20_17  
  4 9,359 1,180
ORIGINAL ARTICLES
Tuberculin purified protein derivative immunotherapy in the treatment of viral warts
Ajay Nimbalkar, Sushil Pande, Ramesh Sharma, Milind Borkar
January-June 2016, 2(1):19-23
DOI:10.4103/2455-3972.184103  
  3 8,046 444
A clinical study of severe cutaneous adverse drug reactions and role of corticosteroids in their management
Rohini Sharma, Naina Dogra, Devraj Dogra
January-June 2017, 3(1):20-23
DOI:10.4103/ijdd.ijdd_22_16  
  3 1,585 183
REVIEW ARTICLE
Apremilast: A dermatologic perspective
Aditya Kumar Bubna
July-December 2016, 2(2):75-82
DOI:10.4103/2455-3972.196166  
  3 10,543 1,412
BRIEF REPORT
Successful use of oral acitretin in oral lichen planus
Ajay Deshpande
January-June 2017, 3(1):24-27
DOI:10.4103/ijdd.ijdd_9_17  
  2 2,711 152
EDITORIAL
Clinical failure of antifungal therapy of dermatophytoses: Recurrence, resistance, and remedy
Ragunatha Shivanna, Arun C Inamadar
January-June 2017, 3(1):1-3
DOI:10.4103/ijdd.ijdd_13_17  
  2 6,157 824
VIVA VOCE
Rituximab in the treatment of skin diseases
Murlidhar Rajagopalan, Resham Vasani
July-December 2017, 3(2):105-109
DOI:10.4103/ijdd.ijdd_31_17  
  2 3,205 394
BRIEF REPORT
Oral acyclovir for severe hand, foot and mouth disease
Dhananjay K Damle
July-December 2018, 4(2):73-75
DOI:10.4103/ijdd.ijdd_35_18  
  1 9,256 203
EDITORIAL
Tranexamic acid in melasma: Why and how?
Shuken Dashore, Katyain Mishra
July-December 2017, 3(2):61-63
DOI:10.4103/ijdd.ijdd_37_17  
  1 34,927 937
Omalizumab in the treatment of chronic urticaria
Kiran Godse
January-June 2018, 4(1):1-2
DOI:10.4103/ijdd.ijdd_19_18  
  1 2,961 247
LETTERS TO EDITOR
Azathioprine-induced alopecia as an early clinical marker of its myelotoxicity
Anil B Bhokare
January-June 2017, 3(1):40-41
DOI:10.4103/ijdd.ijdd_4_17  
  1 8,407 100
First mobile application - Lepra reaction basic management guide - Stress on steroids
Pugazhenthan Thangaraju
July-December 2018, 4(2):85-86
DOI:10.4103/ijdd.ijdd_18_18  
  1 263 65
Gliptin-induced bullous pemphigoid-Case report
Dhanashree S Bhide, Tejaswini S Salunke, Paras Choudhary
July-December 2018, 4(2):86-87
DOI:10.4103/ijdd.ijdd_26_18  
  1 1,041 78
Levetiracetam-induced maculopapular rash: A rare side effect
Mahesh M Unni, Dinesh Verma, Ruikar Devashish
July-December 2016, 2(2):109-111
DOI:10.4103/2455-3972.196204  
  1 2,637 85
MANAGING A SIDE EFFECT
Oral retinoid-induced cheilitis
Bhushan Madke, Hiral Shah, Adarsh Lata Singh, Meenaz Khoja, Poonam Kabra
January-June 2016, 2(1):50-53
DOI:10.4103/2455-3972.184104  
  1 3,902 196
VIVA VOCE
Viva Voce on omalizumab
Kiran Godse, Resham Vasani
July-December 2016, 2(2):121-123
DOI:10.4103/2455-3972.196227  
  1 1,646 203
* Source: CrossRef